SVA versus othersI bought SVA many years ago and have just let it ride. I thought that with the strict protocols established for the Ph I/II trials, the report was good news and, after seeing Dr Shapiro today on Global's Health Matters I cannot see they are near the same juncture as SVA and, even with Hemostemix joining Dr. Sparling's research, I cannot see them proving a more viable option than SVA's. I believe the Doctor. has been in this type of research since the late 1990's. If the pouch with micro-encapsulated cells is successful then so is SVA , and SVA has other omission type therapies to proceed with. Am I wrong?.